Subclinical Pre-Treatment Sensory Deficits Appear to Predict the Development of Pain and Numbnessin Patients with Multiple Myeloma Undergoing Chemotherapy

PURPOSE: Chemotherapy-induced peripheral neuropathy is a major complication in the treatment of cancer, including multiple myeloma (MM). Patients may develop painful and nonpainful (e.g., numbness) neuropathy symptoms that impair function and often persist after therapy is terminated. This study tes...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Vichaya, Elisabeth G., Wang, Xin Shelley, Boyette-Davis, Jessica A., Mendoza, Tito R., He, Zijing, Thomas, Sheeba K., Shah, Nina, Williams, Loretta A., Cleeland, Charles S., Dougherty, Patrick M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669643/
https://ncbi.nlm.nih.gov/pubmed/23543296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2152-7
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg